TRYAL : From Investor Story To Buyer-Ready Brand

The Goal

TRYAL had built credibility in clinical trial technology, but its story was still geared primarily toward investors. As the company prepared to move more aggressively into AI, leadership needed a brand and message built for a different audience: buyers. The challenge was to sharpen what made TRYAL valuable, create a differentiated position for its future, and do it without losing the equity of its legacy product or clinical technology expertise.

What We Built

Clarus led the leadership team through a strategic brand workshop and built the foundation for the next version of TRYAL.

The Impact

In just three months, TRYAL went from having a sophisticated product story that required significant explanation to having a clear, consistent brand story that could work across sales, marketing, PR, and leadership communications.